Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;9(4):932-3.
doi: 10.1177/1932296815580162. Epub 2015 Apr 7.

Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes

Amanda J Young  1 , Hood Thabit  2 , Simon R Heller  3 , Mark L Evans  2 , Stephanie A Amiel  4 , Roman Hovorka  2 , Katharine D Barnard  5
Affiliations

Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes

Amanda J Young et al. J Diabetes Sci Technol. 2015 Jul.
No abstract available

Keywords: HbA1c; artificial pancreas; closed-loop technology; continuous glucose monitor; psychosocial impact.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: AJY, HT, and SAA declare no conflicts of interest. SRH reports speaker honoraria from Eli Lilly, Novo Nordisk, serving on advisory panels for Eli Lilly, NovoNordisk for which his institution has received remuneration and receiving research support from Medtronic. MLE has received speaker honoraria from Roche, Animas, Ypsomed, Abbott Diabetes Care, Eli Lilly, NovoNordisk; served on advisory panels for Roche, Medtronic, CellNovo; and holds stock options in CellNovo. RH reports having received speaker honoraria from Minimed Medtronic, Lifescan, Eli Lilly, BBraun, and Novo Nordisk, serving on advisory panel for Animas, Minimed Medtronic, and Eli Lilly, receiving license fees from BBraun and Beckton Dickinson, and having served as a consultant to Beckton Dickinson, BBraun, Sanofi-Aventis, and Profil. KDB reports having received speaker honoraria from Roche Diagnostics, Lifescan, Novo Nordisk, and Animas and serving on global advisory board for Roche and as a consultant to Sanofi-Aventis.

References

    1. Thabit H, Lubina-Solomon A, Stadler M, et al. Home use of closed loop insulin delivery improves overnight glucose control in adults with type 1 diabetes: a four-week multicentre randomised crossover study. Lancet Diabetes Endocrinol. 2014;2:701-709. - PMC - PubMed
    1. Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care. 2014;37:1204-1211. - PMC - PubMed
    1. Thabit H, Hovorka R. Bringing closed-loop home: recent advances in closed-loop insulin delivery. Curr Opin Endocrinol Diabetes Obes. 2014;21(2):95-101. - PubMed
    1. Barnard KD, Wysocki T, Allen JM, et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care. 2014;2:e000025. doi: 10.1136/bmjdrc-2014-000025. - DOI - PMC - PubMed
    1. Barnard KD, Wysocki T, Thabit H, et al. Psychosocial aspects of closed-loop and open-loop delivery: closing the loop in adults with type 1 diabetes in the home setting [published online ahead of print January 23, 2015]. Diabetes Med. doi: 10.1111/dme.12706. - DOI - PubMed

Publication types